This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Agha, A. Articles by Stewart, P. M. Search for Related Content PubMed PubMed Citation Articles by Agha, A. Articles by Stewart, P. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB HYDROCORTISONE Related Collections Adrenal and Hypertension Neuroendocrinology and Pituitary

The Long-Term Predictive Accuracy of the Short Synacthen (Corticotropin) Stimulation Test for Assessment of the Hypothalamic-Pituitary-Adrenal Axis

Division of Medical Sciences (A.A., J.W.T., P.M.S.), University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, United Kingdom; and Regional Endocrine Laboratory (P.M.C., G.H.), University Hospital Birmingham, B29 6JD Birmingham, United Kingdom

Address all correspondence and requests for reprints to: Dr. Amar Agha, Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, United Kingdom. E-mail: a.agha{at}qmul.ac.uk.

Context: The high-dose short Synacthen (corticotropin) test (SST) is widely used to investigate suspected secondary adrenal insufficiency, but concern remains about falsely reassuring results.

Objective: Our objective was to evaluate the long-term safety of the SST.

Method: We retrospectively evaluated the clinical outcome in 178 patients who achieved 30-min cortisol values in the lowest 15th percentile of normal healthy responses. Thirty patients were later excluded because of missing case notes (20 patients) or unsubstantiated pituitary pathology (10 patients). The remaining 148 patients were divided into two groups: group 1, patients with cortisol response between the 5th and 15th percentiles of normal response (551–635 nmol/liter, 98 patients); and group 2, patients with borderline response between the 2.5th and 5th percentiles (510–550 nmol/liter, 50 patients). Patients did not receive routine glucocorticoid therapy, but those in group 2 were advised to take hydrocortisone in case of intercurrent illness.

Results: The median follow-up period from the initial SST was 4.2 yr (range, 4 months to 7 yr). A total of 137 patients showed no clinical or biochemical evidence of adrenal insufficiency during follow-up. Of the remaining 11 patients, seven became hypoadrenal after subsequent pituitary surgery or radiotherapy, one patient in group 1 developed adrenal insufficiency at 2 yr, and one patient in group 2 developed adrenal insufficiency at 6 months. The other two patients who were in group 2 had clinical diagnostic uncertainty.

Conclusion: The high-dose SST is safe for the purpose of excluding clinically significant secondary adrenal insufficiency and is indicated as the first line of investigation for this purpose.

This article has been cited by other articles:

				R. P Vincent, F. E Etogo-Asse, T. Dew, W. Bernal, J. Alaghband-Zadeh, and C. W le Roux Serum total cortisol and free cortisol index give different information regarding the hypothalamus-pituitary-adrenal axis reserve in patients with liver impairment Ann Clin Biochem, November 1, 2009; 46(6): 505 - 507. [Abstract] [Full Text] [PDF]

				A. Fernandez, M. Brada, L. Zabuliene, N. Karavitaki, and J. A H Wass Radiation-induced hypopituitarism Endocr. Relat. Cancer, September 1, 2009; 16(3): 733 - 772. [Abstract] [Full Text] [PDF]

				I. Wallace, S. Cunningham, and J. Lindsay The diagnosis and investigation of adrenal insufficiency in adults Ann Clin Biochem, September 1, 2009; 46(5): 351 - 367. [Abstract] [Full Text] [PDF]

				W. Arlt The Approach to the Adult with Newly Diagnosed Adrenal Insufficiency J. Clin. Endocrinol. Metab., April 1, 2009; 94(4): 1059 - 1067. [Abstract] [Full Text] [PDF]

				R. Kazlauskaite, A. T. Evans, C. V. Villabona, T. A. M. Abdu, B. Ambrosi, A. B. Atkinson, C. H. Choi, R. N. Clayton, C. H. Courtney, E. N. Gonc, et al. Corticotropin Tests for Hypothalamic-Pituitary- Adrenal Insufficiency: A Metaanalysis J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4245 - 4253. [Abstract] [Full Text] [PDF]

				S. Melmed Update in Pituitary Disease J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 331 - 338. [Abstract] [Full Text] [PDF]

				S. Siyambalapitiya, V. Ibbotson, A. Doane, E. Ghigo, M. J. Campbell, and R. J. Ross Combining Growth Hormone Releasing Hormone-Arginine and Synacthen Testing Diminishes the Cortisol Response J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 853 - 856. [Abstract] [Full Text] [PDF]